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Abstracts / Osteoarthritis and Cartilage 20 (2012) S54–S296 S263an effective homogenization method and accurate detection. The ten most
abundant proteins that appeared in all 12 runs and are listed in Table 1,
along with the standard deviation. Decorin was the most abundant, fol-
lowed by Prolargin and Collagen I. Finally, various widely used tendon
markers were detected and quantiﬁed (relative abundance). As can be seen
for Tenomodulin, TGF-ß, and collagen (Figure 2), abundance was surpris-
ingly stable in the four biopsies.
Conclusions: This was a single-sample, preliminary proteomic study of
healthy, young tendon. The results presented here demonstrate that a rice-
grain biopsy is sufﬁcient for the extraction of a large range of proteins, and that
theprocess is repeatablebetweenbiopsieswithin the samepatient. It is alsoan
early glance into the content of Hamstring tendon matrix, showing the most
abundant proteins. Interestingly, some of these have not been treated as
tendon markers. Also interesting is the complete absence of Elastin. This
matrix protein has been highlighted in past publications as critical for the
mechanical properties of tendon, but was not detected in any of our samples.
Finally, this study sets the ground for a larger study comparing pooled pop-
ulations. Suchdata can increaseour understandingof thehealthy tendon, help
identify tendon markers, and ultimately, tendon disease markers.
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QUANTITATIVE ANALYIS OF THE EFFECT OF NICOTINE IN THE HUMAN
ARTICULAR CHONDROCYTE SECRETOME
L. Lourido, V. Calamia, P. Fernández-Puente, J. Mateos, B. Rocha,
C. Fernández-Costa, F.J. Blanco, C. Ruiz-Romero. INIBIC-CHUAC. ProteoRed/
ISCIII. Proteomica Group. Rheumatology Div., A Coruña, Spain
Purpose: Osteoarthritis (OA) is a very prevalent degenerative joint disease
that is characterized by articular cartilage degradation, which requires
efﬁcient therapies. Previous studies of our group suggested that smoking
might be a protective factor against OA. In this study, we aimed to evaluate
the possible anti-inﬂammatory/anabolic role of nicotine as modulator of
cartilage extracellular matrix (ECM) turnover using a proteomic approach
based on metabolic labelling of proteins.
Methods:OA and Normal cartilagewas obtained from patients undergoing
joint replacement, and from normal donors without history of joint
disease. Human articular chondrocytes (HACs) were isolated and primary
cultured in a DMEM medium supplemented either with heavy isotopes of
Arg and Lys or with their non-labelled versions for the SILAC (Stable
Isotope Labelling by Amino Acids in Cell Culture) study. HACs were
expanded until the complete labelling of their proteins was achieved.
Then, cells were stimulated with Nicotine (10-500nM), IL-1b (a proin-
ﬂammatory mediator, at 5ng/ml) or the combination of both compounds.
For the proteomic study, HACs secretomes were collected, heavy and light
samples were mixed 1:1 and then separated by SDS-PAGE prior to in gel-
digestion with trypsin. Peptides were further separated and analyzed by
nanoLC-MALDI-TOF/TOF mass spectrometry. The protein identiﬁcation
and quantiﬁcation was carried out using ProteinPilot software.
Results: One hundred and ten (110) different proteins were identiﬁed in the
secretome of normal and OA chondrocytes, 90% of them with a predicted
extracellular localization. In normal chondrocytes treated with nicotine, we
detected 13 modulated proteins; IL-6 and Fibronectine, two proteins
involved in the inﬂammatory responseproteins,were increased signiﬁcantly.
Extracellular matrix proteins such asMMP1 andMMP3were also increased.
In addition, results revealed a nicotine-dependent increase of amodulator ofTable 1
Association of change in impairment with treatment response (Responder Vs Non Respo
Impairment Change Impairment Status N % Tr
Knee Instability Not Improved 103 28.2
Improved 49 49.0
Hamstring Flexibility Not Improved 80 42.5
Improved 67 28.4
Knee Extension ROM Not Improved 58 27.6
Improved 89 41.6
Fear of Physical Activity Not Improved 66 43.4
Improved 86 56.6
Depressive Symptoms Not Improved 78 41.0
Improved 74 28.4TGFbeta activity (LTBP2) and typeVI collagen. InOAchondrocytes stimulated
with nicotine, we detected 4 signiﬁcant modulated proteins in the secre-
tome, from of all them, COMP was decreased signiﬁcantly.
Conclusions: We have studied the nicotine-mediated modulation of
articular cartilage ECM proteins, using an in vitro model of primary HACs.
These results suggest that, in our model of stimulated-IL-1 chondrocytes,
nicotine (50nM) is not able to counteract the inﬂammatory effect caused
by IL-1b (5ng/mL) on normal human chondrocytes.
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ASSOCIATIONS BETWEEN CHANGES IN IMPAIRMENTS AND TREATMENT
RESPONSE FOLLOWING EXERCISE THERAPY IN SUBJECTS WITH KNEE
OSTEOARTHRITIS
G.K. Fitzgerald 1, D.K. White 2, S.R. Piva 1. 1Univ. of Pittsburgh, Pittsburgh, PA,
USA; 2Boston Univ., Boston, MA, USA
Purpose: Exercise can improve pain and function in knee osteoarthritis
(KOA) but the treatment effects are often small to moderate at best.
Exercise programs for people with KOA are typically designed to address
impairments that are believed to be contributing to pain, functional deﬁ-
cits and disability. However, there is very little evidence demonstrating
that changes in impairments as a result of exercise actually are associated
with better clinical outcomes. Such knowledge could help in identifying
the active ingredients of response to treatment that could be emphasized
through the reﬁnement of existing exercise therapy paradigms for people
with KOA. The purpose of this exploratory analysis was to examine the
association of changes in impairment with clinical outcome in response to
an exercise program for people with KOA.
Methods: This is an exploratory analysis of data from a randomized trial on
exercise therapy inpeoplewithKOA.Data from152subjectswere included in
the analysis. Subjects had completed an exercise programconsistingof lower
extremity strengthening, stretching, rangeofmotion, balanceandagility, and
aerobic exercises. Impairment measures included self-reported knee insta-
bility, quadriceps strength, knee range of motion, lower extremity muscle
ﬂexibility, fear of physical activity, anxiety, and depressive symptoms. The
change from baseline to the 2 month follow-up visit was calculated for each
impairment and change scores were then converted to a dichotomous
variable of improved or not improved. Clinical outcome was a dichotomous
variable of responder or non-responder, with responders being those who
had a minimum of a 20% change from baseline in BOTH the Numerical Pain
Rating Scale (NKPR) and theWOMACphysical function scale. The association
of each impairment change variablewith treatment responsewas examined
with unadjusted logistic regression analyses. Those univariate associations
signiﬁcant at the .10 level were then included in a multivariate logistic
regressionmutuallyadjusted forother impairment changevariablesmeeting
this criteria along with age, sex, BMI, and exercise group.
Results: Change in knee instability, hamstring ﬂexibility, knee extension
range of motion, fear of physical activity, and depressive symptoms were
each associated with a positive response to treatment. When these vari-
ables were included in the multivariate analysis, improvement in self-
reported knee instability was associated with a 60% increase in odds of
treatment response compared with those without improvement in knee
instability (OR ¼ 1.6, 95% CI[1.08, 2.24]) (see Table 1).nder)
eatment Responders Adjusted Odds Ratio(OR) 95% CI (OR)
1.0 Reference
1.6 1.08-2.24
1.0 Reference
.60 0.29-1.24
1.0 Reference
1.8 0.86-3.90
1.0 Reference
1.8 0.83-3.76
1.0 Reference
.51 0.25-1.06
